Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rebus Holdings, Inc. (NSPX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2017 |
3
| Montgomery John Robison (Director) has filed a Form 3 on Inspyr Therapeutics, Inc. |
| 08/15/2017 |
4
| Hansen Bo Jesper (Director) has filed a Form 4 on Inspyr Therapeutics, Inc.|
Txns:
| Granted 1,667 options to buy
@ $0.35, valued at
$583.5 |
|
| 08/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/06/2017 |
4
| OGILVIE SCOTT VARDE (Director) has filed a Form 4 on Inspyr Therapeutics, Inc.|
Txns:
| Granted 2,335 options to buy
@ $0.54, valued at
$1.3k
|
|
| 10/28/2016 |
4
| Hansen Bo Jesper (Director) has filed a Form 4 on Inspyr Therapeutics, Inc. |
| 10/24/2016 |
3
| Thom Claire (Director) has filed a Form 3 on Inspyr Therapeutics, Inc. |
| 10/24/2016 |
3
| Buller Richard E (Director) has filed a Form 3 on Inspyr Therapeutics, Inc. |
| 08/18/2016 |
3
| LOWE CHRISTOPHER P. (President and CEO) has filed a Form 3 on Inspyr Therapeutics, Inc. |
| 08/17/2016 |
3
| SHAZER RONALD L (Chief Medical Officer) has filed a Form 3 on Inspyr Therapeutics, Inc. |
| 07/14/2016 |
4
| GREBOW PETER E (Director) has filed a Form 4 on GENSPERA INC|
Txns:
| Granted 53,000 options to buy
@ $0.1325, valued at
$7k
|
|
| 03/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|